Cambium Secures $5 Million in Series A Funding
Proceeds To Fund in Part Cambium’s Upcoming FDA Dry Eye Study ATLANTA, GA – October 6, 2017 – Cambium Medical Technologies (“Cambium”), a clinical stage company, announced today a Series A investment of $5 million from a private investor. “This funding’s timing is perfect given recent news the FDA reviewed our Phase I/II dry eye ...
Read more